ash_hematology

As treatment options for sickle cell disease continue to expand, understanding how clinical outcomes compare with treatment costs is increasingly important. 

New research published in Blood found that stem cell transplantation was the most cost-effective treatment option for adults living with sickle cell disease when compared with gene therapy and standard of care. 

Read the press release for more! 🔗link in bio